Hemocompatibility of surface-modified, silicon-incorporated, diamond-like carbon films
- Hemocompatibility of surface-modified, silicon-incorporated, diamond-like carbon films
- R.K. Roy; H.W. Choi; 이진우; 문명운; 이광렬; 한동근; 신지훈; A. Kamijo; T. Hasebe
- DLC; biocompatibility; stent; NiTi; surface modification; hydrophilic; hemocompatibility; platelet adhesion; polar component; diamond-like carbon
- Issue Date
- Acta Biomaterialia
- VOL 5, NO 1, 249-256
- The hemocompatibility of plasma-treated, silicon-incorporated, diamond-like carbon (Si-DLC) films was investigated. Si-DLC films with a Si concentration of 2 at.% were prepared on Si (100) or Nitinol substrates using a capacitively coupled radiofrequency plasmaassisted chemical vapor deposition method using a mixed gas of benzene (C6H6) and diluted silane (SiH4:H2 = 10:90). The Si-DLC films were then treated with O2, CF4 or N2 glow discharge for surface modification. The plasma treatment revealed an intimate relationship between the polar component of the surface energy and its hemocompatibility. All in vitro characterizations, i.e. protein absorption behavior, activated partial thromboplastin time measurement and platelet adhesion behavior, showed improved hemocompatibility of the N2-- or O2-plasma-treated surfaces where the polar component of the surface energy was significantly increased. Si–O or Si–N surface bonds played an important role in improving hemocompatibility, as observed in a model experiment. These results support the importance of a negatively charged polar component of the surface in inhibiting fibrinogen adsorption and platelet adhesion.
- Appears in Collections:
- KIST Publication > Article
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.